Cholesterol and atherosclerosis

Australian and New Zealand Journal of Medicine

Volumn 27, Issue 4, 1997, Pages 492-496

  Kroon, Paulus A ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Atherosclerosis; Cholesterol; Low density lipoprotein; Low density lipoprotein receptor; Scavenger receptor

Indexed keywords

LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ATHEROGENESIS; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL TRANSPORT; CONFERENCE PAPER; HUMAN; MACROPHAGE;

EID: 0030869691     PISSN: 00048291     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-5994.1997.tb02224.x     Document Type: Conference Paper

References (19)

1. Goldstein JL, Brown MS. Familial hypercholesterolemia. In: Scriver CR, Beaudet al, Sly W, Valle D (Eds.). The metabolic and molecular bases of inherited disease. 7th edn. New York: McGraw-Hill, 1995; 1981-2030.
2. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. NEnglJMed 1989; 320: 915-24.
3. Esterbauer H, Gebicki J, Puhl H, Jurgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radie Biol Med 1992; 13: 341-90.
4. Campbell JH, Campbell GR. The cell biology of atherosclerosis - new developments. Aust NZ J Med 1997; 27: 497-500.
5. Krieger M. Molecular flypaper and atherosclerosis: structure of the macrophage scavenger receptor. Trends Biochem Sci 1992; 17: 141-6.
6. Bieri S, Djordjevic JT, Daly NL, Smith R, Kroon PA. Bisulfide bridges of a cysteine-rich repeat of the LDL receptor ligand-binding domain. Biochemistry 1995; 34: 13059-65.
7. Daly NL, Djordjevic JT, Kroon PA, Smith R. Three-dimensional structure of the second cysteine-rich repeat from the human low-density lipoprotein receptor. Biochemistry 1995; 34: 14474-81.
8. Kroon PA, Powell EE. Liver, lipoproteins and disease: I. Biochemistry of lipoprotein metabolism. J Gastroenterol Hepatol 1992; 7: 214-22.
9. Elovson J, Chatterton JE, Bell GT et al. Plasma very low density lipoproteins contain a single molecule of apolipoprotein B. J Lipid Res 1988; 29: 1461-73.
10. Olivecrona G, Olivecrona T. Triglyceride Upases and atherosclerosis. Curr Opin Lipidol 1995; 6: 291-305.
11. Tall AR. Plasma lipid transfer proteins. J Lipid Res 1986; 27: 361-7.
12. Havel RJ, Hamilton RL. Hepatocytic lipoprotein receptors and intracellular lipoprotein catabolism. Hepatology 1988; 8: 1689-704.
13. Kesaniemi YA, Beltz WF, Grundy SM. Comparisons of metabolism of apolipoprotein B in normal subjects, obese patients, and patients with coronary heart disease. J Clin Invest 1985; 76: 586-95.
14. Demant T, Carlson LA, Holmquist L et al. Lipoprotein metabolism in hepatic lipase deficiency: studies on the turnover of apolipoprotein B and on the effect of hepatic lipase on high density lipoprotein. J Lipid Res 1988; 29: 1603-11.
15. Spady DK, Billheimer DW, Dietchy JM. Rates of receptor-dependent and -independent low density lipoprotein uptake in the hamster. Proc Natl Acad Sci USA 1983; 80: 3499-503.
16. Brown MS, Goldstein JL. A receptor-mediated pathway for cholesterol homeostasis. Science 1986; 232: 34-47.
17. Brown MS, Goldstein JL. The LDL receptor and HMG-CoA reductase - two membrane molecules that regulate cholesterol homeostasis. Curr Top Cell Regul 1985; 26: 3-15.
18. Shimano H, Horton JD, Hammer RE, Shimomura I, Brown MS, Goldstein JL. Overproduction of cholesterol and fatty acids causes massive liver enlargement. J Clin Invest 1996; 98: 1575-84.
19. Stark RM. Review of the major intervention trials of lowering coronary artery disease risk. Am J Cardiol 1996; 78: 13-9.